Ignite Creation Date:
2024-05-06 @ 3:48 AM
Last Modification Date:
2024-10-26 @ 11:38 AM
Study NCT ID:
NCT02370888
Status:
TERMINATED
Last Update Posted:
2020-01-27
First Post:
2015-02-10
Brief Title:
Lenalidomide After Allo-Hematopoietic Cell Transplant HCT in Acute Myelogenous Leukemia AML and Myelodysplastic Syndromes MDS Subjects With Minimal Residual Disease
Sponsor:
University of Florida
Organization:
University of Florida
Organization Data
Organization:
University of Florida
Class:
OTHER
Study ID:
WIRB20151509
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Florida
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |